These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15122304)

  • 21. Familial amyloid polyneuropathy: a clinico-pathologic study.
    Said G; Planté-Bordeneuve V
    J Neurol Sci; 2009 Sep; 284(1-2):149-54. PubMed ID: 19467548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver transplantation in transthyretin-related familial amyloid polyneuropathy.
    Stangou AJ; Hawkins PN
    Curr Opin Neurol; 2004 Oct; 17(5):615-20. PubMed ID: 15367866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transthyretin familial amyloidotic polyneuropathy: histopathological study of the explanted livers.
    Amante MF; Trigo P; Lendoire J; Imventarza O; Parisi C
    Ann Hepatol; 2003; 2(4):171-4. PubMed ID: 15115956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology.
    Bergström J; Gustavsson A; Hellman U; Sletten K; Murphy CL; Weiss DT; Solomon A; Olofsson BO; Westermark P
    J Pathol; 2005 Jun; 206(2):224-32. PubMed ID: 15810051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acquired transthyretin amyloidosis after domino liver transplant: Phenotypic correlation, implication of liver retransplantation.
    Muchtar E; Grogan M; Dasari S; Kurtin PJ; Gertz MA
    J Neurol Sci; 2017 Aug; 379():192-197. PubMed ID: 28716239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling.
    Sousa MM; Saraiva MJ
    Prog Neurobiol; 2003 Dec; 71(5):385-400. PubMed ID: 14757117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Familial amyloid polyneuropathy].
    Yamashita T; Ando Y; Uchino M
    Brain Nerve; 2011 Jun; 63(6):583-95. PubMed ID: 21613661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Familial amyloid polyneuropathy: liver transplantation as first-line therapy].
    Yamashita T
    Brain Nerve; 2014 Jul; 66(7):763-71. PubMed ID: 24998821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Schwann cells contribute to neurodegeneration in transthyretin amyloidosis.
    Murakami T; Sango K; Watabe K; Niimi N; Takaku S; Li Z; Yamamura K; Sunada Y
    J Neurochem; 2015 Jul; 134(1):66-74. PubMed ID: 25693163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapeutic strategy for familial amyloid polyneuropathy (FAP)].
    Ikeda S
    Rinsho Shinkeigaku; 2009 Nov; 49(11):953-5. PubMed ID: 20030258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and pathological findings in familial amyloid polyneuropathy caused by a transthyretin E61K mutation.
    Murakami T; Nishimura H; Nagai T; Hemmi S; Kutoku Y; Ohsawa Y; Sunada Y
    J Neurol Sci; 2017 Oct; 381():55-58. PubMed ID: 28991715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of age and sex differences on wild-type transthyretin amyloid formation in familial amyloidotic polyneuropathy: a proteomic approach.
    Tasaki M; Ueda M; Obayashi K; Koike H; Kitagawa K; Ogi Y; Jono H; Su Y; Suenaga G; Oshima T; Misumi Y; Yoshida M; Yamashita T; Sobue G; Ando Y
    Int J Cardiol; 2013 Dec; 170(1):69-74. PubMed ID: 24182678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity.
    Ikeda S; Nakazato M; Ando Y; Sobue G
    Neurology; 2002 Apr; 58(7):1001-7. PubMed ID: 11940682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical picture and outcome of transthyretin-related familial amyloid polyneuropathy (FAP) in Japanese patients.
    Ikeda S
    Clin Chem Lab Med; 2002 Dec; 40(12):1257-61. PubMed ID: 12553427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A low amyloidogenic E61K transthyretin mutation may cause familial amyloid polyneuropathy.
    Murakami T; Yokoyama T; Mizuguchi M; Toné S; Takaku S; Sango K; Nishimura H; Watabe K; Sunada Y
    J Neurochem; 2021 Mar; 156(6):957-966. PubMed ID: 32852783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of the heat shock response in familial amyloidotic polyneuropathy.
    Santos SD; Magalhães J; Saraiva MJ
    J Neuropathol Exp Neurol; 2008 May; 67(5):449-55. PubMed ID: 18431252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy.
    Taguchi K; Jono H; Kugimiya-Taguchi T; Nagao S; Su Y; Yamasaki K; Mizuguchi M; Maruyama T; Ando Y; Otagiri M
    Life Sci; 2013 Dec; 93(25-26):1017-22. PubMed ID: 24211615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum transthyretin monomer in patients with familial amyloid polyneuropathy.
    Sekijima Y; Tokuda T; Kametani F; Tanaka K; Maruyama K; Ikeda S
    Amyloid; 2001 Dec; 8(4):257-62. PubMed ID: 11791618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathological changes long after liver transplantation in a familial amyloidotic polyneuropathy patient.
    Obayashi K; Ueda M; Oshima T; Kawahara S; Misumi Y; Yamashita T; Jono H; Yazaki M; Kametani F; Ikeda S; Ohya Y; Asonuma K; Inomata Y; Ando Y
    BMJ Case Rep; 2012 Aug; 2012():. PubMed ID: 22907857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of familial amyloid polyneuropathy].
    Adams D; Samuel D; Slama M
    Presse Med; 2012 Sep; 41(9 Pt 1):793-806. PubMed ID: 22341949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.